NOVAREX Co.,Ltd. (KOSDAQ:194700)

Market Cap	314.39B
Revenue (ttm)	331.88B
Net Income (ttm)	26.40B
Shares Out	17.70M
EPS (ttm)	1,491.00
PE Ratio	11.91
Forward PE	n/a
Dividend	200.00 (1.13%)
Ex-Dividend Date	Dec 27, 2024

Volume	129,541
Average Volume	281,011
Open	17,670
Previous Close	17,670
Day's Range	17,260 - 18,020
52-Week Range	6,650 - 18,740
Beta	0.29
RSI	63.84
Earnings Date	Aug 11, 2025

About NOVAREX

NOVAREX Co.,Ltd. manufactures, wholesales, and retails health and functional foods in South Korea and internationally. It offers lactic acid bacteria, omega-3, icle time, eye health, diet, boswellia, and lutein and zeaxanthin, as well as vitamin and mineral products in the form of tablets, soft and hard capsules, powder, liquid, gel, and jellies. The company was formerly known as Health Science Co., Ltd. and changed its name to NOVAREX Co.,Ltd. in November 2013. NOVAREX Co.,Ltd. was founded in 1995 and is headquartered in Cheongju-si, South Kor...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 436
• Stock Exchange: KOSDAQ
• Ticker Symbol: 194700

Financial Performance

In 2024, NOVAREX's revenue was 297.73 billion, a decrease of -1.47% compared to the previous year's 302.17 billion. Earnings were 23.02 billion, an increase of 4.45%.